Ajenat Pharmaceuticals is advancing access to high-quality, complex generics for human and animal health. We combine precision manufacturing with a relentless commitment to innovation, safety, and global impact.
With over a decade of expertise in pharmaceutical manufacturing, Ajenat is a US-based company specializing in the development of beta-lactam, cephalosporin, and other high-barrier generics. Operating from our cGMP-certified facility in Largo, Florida, we deliver robust R&D, scalable production, and regulatory-compliant solutions for partners worldwide.
Our growing portfolio includes a diverse range of FDA-approved generic products spanning multiple therapeutic areas. With a strong focus on quality, bioequivalence, and availability, Ajenat is committed to helping meet critical patient needs at scale.
From contract manufacturing to co-development, we offer flexible engagement models for pharmaceutical companies looking to scale operations, enter the US market, or bring complex generics to life. Let’s build something impactful-together.
Our state-of-the-art facility supports full-cycle pharmaceutical development—from lab-scale formulation to commercial packaging. With advanced containment systems and rigorous QA/QC protocols, we’re built for precision, performance, and compliance. Opportunities Include:
© 2025 AJENAT PHARMACEUTICALS. All rights reserved.
© 2025 AJENAT PHARMACEUTICALS. All rights reserved.
